FDA 483 - ImClone Systems, LLC - August 21, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
ImClone Systems, L.L.C. in Branchburg, NJ, a biological drug substance manufacturer, was cited for significant quality system and laboratory control deficiencies. The firm failed to thoroughly investigate unexplained discrepancies and batch failures, often misclassifying serious GMP violations as minor observations. Additionally, laboratory controls lacked scientifically sound and consistent test procedures for drug substances, leading to uncontrolled and irreproducible purity method results.
ID · db44c46a-32b3-4767-929a-56d701d813ae